ea0037gp.22.02 | Pituitary–Therapy of Cushing's disease | ECE2015
Johnston Philip C
, Hamrahian Amir H
, Bena Jim
, Weil Bob
, Kennedy Laurence
Background: Transsphenoidal tumour resection (TSS) is the first-line treatment for CushingÂ’s disease (CD). With an experienced neurosurgeon, immediate remission rates >80% are expected for patients with microadenomas (<10 mm).Aim: To report initial and long-term remission rates in a specialist centre, and to ascertain factors associated with disease recurrence after TSS.Methods: Patients with CD (n=101, 28M, 7...